Live Breaking News & Updates on Greg Keenan

Stay updated with breaking news from Greg keenan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Long-Term Data, Renal Function Monitoring Update Added to Lupkynis Labeling

Long-Term Data, Renal Function Monitoring Update Added to Lupkynis Labeling
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

Greg Keenan , Chief Medical Officer ,

Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024

Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Ernie Lee , Lily Cipolla , Lisa Kennedy , Matt Truman , Ronald Flauto , Michelle Zubrycki , Ernie Yap , Stephen Myers , Lucys Hodge , Maria Dallera , Anca Askanase , Vanessa Birardi , Greg Keenan , Neil Solomons , Ron Flauto , Kenneth Kalunian , Long Beach Convention Entertainment Center , Product Service , European Commission , National Kidney Foundation , Clinical Program , Institute For Clinical , Drug Administration , Pnational Kidney Foundation Spring Clinical Meeting , Aurinia Pharmaceuticals Inc ,

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United States , Gabriel Contreras , Ernie Yap , Matt Truman , Neil Solomons , Andrea Christopher , Kenneth Kalunian , Matthewg Baker , Greg Keenan , Maria Dallera , Anca Askanase , Lucys Hodge , Aurinia Pharmaceuticals Inc , European Commission , Drug Administration , Clinical Program , Corporate Communications Investor Relations , Aurinia Pharmaceuticals , Clinical Rheumatology , Aspreva Lupus Management Study , Chief Medical Officer , Propensity Analysis , Maria Dall Era , Long Term Safety , Black Patients , Red Cell Aplasia ,

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17. ....

United States , Farzin Haque , Greg Keenan , Stacy Ku , Andrea Christopher , Joe Miller , Peter Greenleaf , Maury Raycroft , Investor Relations For Aurinia Pharmaceuticals , Exchange Commission , Aurinia Pharmaceuticals First Quarter , Head Of Corporate Communications , Aurinia Pharmaceuticals Inc , Aurinia Pharmaceuticals , Call Transcript May , Corporate Communications , Investor Relations , Chief Executive Officer , Chief Financial Officer , Chief Medical , Lupus Awareness , Highest Rates , Stomach Cancer , Cheapest Cities To Retire ,

Long-Term Data, Renal Function Monitoring Update Added to Lupkynis Labeling

The updated label now includes 3-year data from AURORA 2, a double-blind, placebo-controlled extension study. ....

Greg Keenan , Chief Medical Officer ,